We gave background to Inside Health Policy

Inside Health Policy used APC for information in its piece “Uncertainty Looms Over Bulk Production Of Personalized GLP-1 Drugs.”

Related posts

The Washington Post’s story “Eli Lilly ramps up its fight against imitation weight-loss drugs”...

NPR ran an updated story on the ‘battle’ between compounders and drug makers over GLP-1 weight-loss...

In a piece on the battle between Eli Lilly and compounding pharmacists over tirzepatide — notably...